EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

Session comprising selected EuroPCR 2021 Hotlines & Late-Breaking Trials submissions

Summary

Find out more about various studies & registries in imaging:

  • A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
  • Impact of different optimal stent implantation definitions in OCT-guide PCI
  • Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
  • 7.5 years follow-up after OCT-guided PCI: report from the CLI-OPCI registry

Presentations available when logged in:

  • A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
  • Impact of different optimal stent implantation definitions in OCT-guide PCI
  • Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
  • 7.5 years follow-up after OCT-guided PCI: report from the CLIO-PCI registry